Skip to content
healthcare.dev

Capecitabine

NDC 59651-204, Capecitabine, tablet, from Aurobindo Pharma Limited.

Product NDC
59651-204
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210604
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CAPECITABINE150 mg/1

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
59651-204-10596510204101 BLISTER PACK in 1 CARTON (59651-204-10) / 10 TABLET in 1 BLISTER PACK
59651-204-605965102046060 TABLET in 1 BOTTLE (59651-204-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/56441153-a1e5-4fdc-96d6-f21baa6b5fbe
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=59651-204
  • NADAC price for package 59651020460

    GET /v1/drugs/nadac/59651020460

Use it

Look up 59651-204 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.